UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review

Clinical infectious diseases, 2023-08, Vol.77 (Supplement_3), p.S238-S244

2023

Volltextzugriff (PDF)

Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults

Digestive diseases and sciences, 2022-06, Vol.67 (6), p.2600-2607

2022

Volltextzugriff (PDF)

National trends in retreatment of HCV due to reinfection or treatment failure in Australia

Journal of hepatology, 2023-02, Vol.78 (2), p.260-270

2023

Volltextzugriff (PDF)

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia

Journal of hepatology, 2021-02, Vol.74 (2), p.293-302

2021

Volltextzugriff (PDF)

Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1502-1510

2020

Volltextzugriff (PDF)

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM

Current opinion in infectious diseases, 2019-02, Vol.32 (1), p.31-37

2019

Volltextzugriff (PDF)

Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic

The Journal of infectious diseases, 2020-12, Vol.222 (Supplement_9), p.S758-S772

2020

Volltextzugriff (PDF)

Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study

The International journal of drug policy, 2022-11, Vol.109, p.103828, Article 103828

2022

Volltextzugriff (PDF)

Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection

Medical journal of Australia, 2021-04, Vol.214 (6), p.279-280

2021

Volltextzugriff (PDF)

Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses Among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent's Hospital and Associated Screening Clinics, Sydney, NSW

Clinical infectious diseases, 2021-05, Vol.72 (10), p.e649-e651

2021

Volltextzugriff (PDF)

Management of acute HCV infection in the era of direct-acting antiviral therapy

Nature reviews. Gastroenterology & hepatology, 2018-07, Vol.15 (7), p.412-424

2018

Volltextzugriff (PDF)

How I manage severe bacterial infections in people who inject drugs

Clinical microbiology and infection, 2024-07, Vol.30 (7), p.877-882

2024

Volltextzugriff (PDF)

Reply to Dr Martinez: Refining Our Understanding of the Association Between Integrase Inhibitor Therapy and Elevations in Blood Pressure

Clinical infectious diseases, 2024-06

2024

Volltextzugriff (PDF)

Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?

Journal of acquired immune deficiency syndromes (1999), 2020-08, Vol.84 (5), p.527-533

2020

Volltextzugriff (PDF)

Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2164-e2172

2021

Volltextzugriff (PDF)

Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs

Clinical infectious diseases, 2021-04, Vol.72 (8), p.1392-1400

2021

Volltextzugriff (PDF)

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

Journal of hepatology, 2021-10, Vol.75 (4), p.829-839

2021

Volltextzugriff (PDF)

Prescribing of direct‐acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program

Medical journal of Australia, 2021-10, Vol.215 (7), p.332-333

2021

Volltextzugriff (PDF)

Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study

Clinical infectious diseases, 2021-12, Vol.73 (11), p.2037-2044

2021

Volltextzugriff (PDF)

Don’t Wait: The Benefits of Early Diagnosis in Perinatal Hepatitis C Virus Transmission

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e3347-e3348

2021

Volltextzugriff (PDF)

Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs

Infectious disease clinics of North America, 2018-06, Vol.32 (2), p.371-393

2018

Volltextzugriff (PDF)

Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus–positive Gay and Bisexual Men?

Clinical infectious diseases, 2020-01, Vol.70 (1), p.106-113

2020

Volltextzugriff (PDF)

Reinfection After Hepatitis C Virus Treatment-Keep Testing, Keep Treating

JAMA network open, 2024-08, Vol.7 (8), p.e2430290

2024

Volltextzugriff (PDF)

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

PloS one, 2015-07, Vol.10 (7), p.e0131437-e0131437

2015

Volltextzugriff (PDF)

Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV

AIDS (London), 2020-07, Vol.34 (9), p.1347-1358

2020

Volltextzugriff (PDF)

1 – 25 von 638

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(557)
Mit Volltextzugriff
(514)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Infectious Diseases
(32)
Journal Of Hepatology
(30)
Aids
(23)
Hepatology
(20)
Plos One
(19)
Clinical Infectious Diseases/clinical Infectious Diseases
(17)
Nature Communications
(14)
Journal Of Viral Hepatitis
(12)
The Journal Of Infectious Diseases
(10)
Antiviral Therapy
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review

Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults

National trends in retreatment of HCV due to reinfection or treatment failure in Australia

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia

Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM

Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic

Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study

Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection

Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses Among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent's Hospital and Associated Screening Clinics, Sydney, NSW

Management of acute HCV infection in the era of direct-acting antiviral therapy

How I manage severe bacterial infections in people who inject drugs

Reply to Dr Martinez: Refining Our Understanding of the Association Between Integrase Inhibitor Therapy and Elevations in Blood Pressure

Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?

Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial

Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

Prescribing of direct‐acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program

Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study

Don’t Wait: The Benefits of Early Diagnosis in Perinatal Hepatitis C Virus Transmission

Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs

Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus–positive Gay and Bisexual Men?

Reinfection After Hepatitis C Virus Treatment-Keep Testing, Keep Treating

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV

Suchergebnisse filtern